Actively Recruiting
Precision Medicine for L/GCMN and Melanoma 2
Led by Fundacion Clinic per a la Recerca Biomédica · Updated on 2025-02-27
100
Participants Needed
3
Research Sites
99 weeks
Total Duration
On this page
Sponsors
F
Fundacion Clinic per a la Recerca Biomédica
Lead Sponsor
H
Hospital Clinic of Barcelona
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective is to evaluate the possibility of using minimally and non-invasive technologies (skin patch and breath analyzer) based on the detection of volatile organic compounds (VOCs) for the early identification of metastases. The secondary objective is to evaluate the usability of these technologies in the follow up of high-risk melanoma patients.
CONDITIONS
Official Title
Precision Medicine for L/GCMN and Melanoma 2
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be over 18 years old
- Have a histopathological confirmed melanoma diagnosis (stage II, III or IV AJCC)
You will not qualify if you...
- Not signing the informed consent form
- Present other cancers or chronic diseases (such as diabetes, asthma, etc.), which may affect the volatile organic compound profiles
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Hospital Clínic de Barcelona (Dermatology service)
Barcelona, Spain, 08036
Not Yet Recruiting
2
Hospital Clínic Barcelona
Barcelona, Spain
Actively Recruiting
3
Hospital Clínic Barcelona
Barcelona, Spain
Actively Recruiting
Research Team
S
Susana Puig Sardà, PhD, MD
CONTACT
A
Adrián López Canosa, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here